Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SBB on its offer for Entra
Mandate

Vinge advises SBB on its offer for Entra

November 30, 2020 Capital Markets and Public M&A Banking and Finance Corporate Tax

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its public offer to the shareholders of Entra ASA.

The total offer consideration consists of a combination of cash and SBB shares, corresponding to a value of approximately NOK 30 billion. SBB is a leading Nordic social infrastructure property company with a property portfolio with a market value of SEK 81.2 billion as of 30 September 2020. SBB’s Class B and Class D common shares are listed on Nasdaq Stockholm, Large Cap. SBB’s preference shares are listed on Nasdaq First North Premier Growth Market.

Vinge’s team consists of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm, Boris Kotur, Martin Boström, Emil Lindwall, Olof Löfvenberg, Lorin Arabi, Mikaela Falkner, Eléonore Friberg and Clara Sohlberg (Capital Markets and Public M&A), Albert Wållgren and Axel Jansson (Banking and Finance) as well as Victor Ericsson (Corporate tax).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025